Janes, A. (2024). Aducanumab: The Controversial New Drug Licensed to Treat Alzheimer’s Disease. Trinity Student Medical Journal , 22(1), 6–11. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/2811